Coherent Introduces Osprey, a Compact Femtosecond Laser for Optogenetics, Microsurgery, and Medical Device Manufacturing

June 23, 2025 01:40 PM PDT | By EODHD

Google News:

Coherent Introduces Osprey, a Compact Femtosecond Laser for Optogenetics, Microsurgery, and Medical Device Manufacturing — Image source: Kalkine Media

Recent News

Ameris Bancorp (NASDAQ:ABCB) Sees Institutional Stake Activity Nasdaq...

Rollins Inc (NYSE:ROL) Sees Activity From Institutions S&P 500

Axon Enterprise (NASDAQ:AXON) Strong Financial Growth Nasdaq Composite

Shake Shack (NYSE:SHAK) Sees Activity in Institutional Nyse Composite

Coherent Corp. SAXONBURG, Pa., June 23, 2025 (GLOBE NEWSWIRE) -- Coherent Corp. (NYSE:COHR), a global leader in photonics, today introduces Osprey, its newest femtosecond laser designed for demanding applications in optogenetics, microsurgery, and medical device manufacturing. Engineered for precision and reliability, Osprey delivers pulse energies of up to 5 µJ and sub-350 fs pulse widths. Osprey delivers exceptional beam quality and pointing stability, all in a compact form factor and with industry-leading power efficiency.

These features make it ideal for integration into precision microscopes and advanced medical tools. The introduction of Osprey comes at a pivotal moment as femtosecond lasers move beyond research settings into clinical and industrial environments. In these applications, repeatability, reliability, beam quality, and cost efficiency have become more critical than peak power. Osprey addresses these evolving needs with industrial-grade reliability, simplified integration, and high performance enabled by the latest ultrafast fiber laser technology. “Osprey combines decades of ultrafast laser expertise with a fiber-based architecture that delivers best-in-class performance and reliability,” said Dr.

Chris Dorman, Executive Vice President, Lasers Business Group at Coherent. “We designed Osprey to deliver clean, stable, high-quality femtosecond pulses with minimal power draw and maximum system stability – a game-changer for medical and life sciences applications.” Osprey’s fiber-based architecture delivers significant performance advantages over competing systems. Leveraging deep expertise in ultrafast fiber technology, the laser generates high-quality pulses using specifically designed solid-core fibers that are virtually free of aging effects while maintaining superior ruggedness and pointing stability. With a power draw under 150 W, Osprey runs on a standard 24 V DC supply. Integrated AOM and wide dispersion pre-compensation enable smooth operation across complex optical paths, critical for wide field-of-view imaging and fiber delivery systems.

Osprey complements the existing ultrafast portfolio from Coherent for two-photon optogenetics, which include the Monaco and the Axon series, optimized for two-photon calcium imaging. Together, this comprehensive lineup provides researchers and engineers with a complete toolkit for advanced bioimaging and microsurgery workflows. Qualification units of Osprey are available, with volume production scheduled for January 2026. Coherent will showcase the Osprey at LASER World of Photonics Munich 2025. Story Continues About Coherent Coherent empowers market innovators to define the future through breakthrough technologies, from materials to systems.

We deliver innovations that resonate with our customers in diversified applications for the industrial, communications, electronics, and instrumentation markets. Coherent has research and development, manufacturing, sales, service, and distribution facilities worldwide. For more information, please visit us at coherent.com. Media Contact: [email protected] View Comments

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations, and video (Content) is a service of Kalkine Media LLC., having Delaware File No. 4697309 (“Kalkine Media, we or us”) and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures/music displayed/used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it, as necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.